These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 19188395)

  • 21. Experimental study of LY333328 (oritavancin), alone and in combination, in therapy of cephalosporin-resistant pneumococcal meningitis.
    Cabellos C; Fernàndez A; Maiques JM; Tubau F; Ardanuy C; Viladrich PF; Liñares J; Gudiol F
    Antimicrob Agents Chemother; 2003 Jun; 47(6):1907-11. PubMed ID: 12760866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacies of BMS 284756 against penicillin-sensitive, penicillin-resistant, and quinolone-resistant pneumococci in experimental meningitis.
    Cottagnoud P; Acosta F; Cottagnoud M; Pfister M; Täuber MG
    Antimicrob Agents Chemother; 2002 Jan; 46(1):184-7. PubMed ID: 11751131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacodynamics of gatifloxacin in cerebrospinal fluid in experimental cephalosporin-resistant pneumococcal meningitis.
    Lutsar I; Friedland IR; Wubbel L; McCoig CC; Jafri HS; Ng W; Ghaffar F; McCracken GH
    Antimicrob Agents Chemother; 1998 Oct; 42(10):2650-5. PubMed ID: 9756771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experimental study of the efficacy of vancomycin, rifampicin and dexamethasone in the therapy of pneumococcal meningitis.
    Martínez-Lacasa J; Cabellos C; Martos A; Fernández A; Tubau F; Viladrich PF; Liñares J; Gudiol F
    J Antimicrob Chemother; 2002 Mar; 49(3):507-13. PubMed ID: 11864951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gemifloxacin is efficacious against penicillin-resistant and quinolone-resistant pneumococci in experimental meningitis.
    Cottagnoud P; Acosta F; Cottagnoud M; Täuber MG
    Antimicrob Agents Chemother; 2002 May; 46(5):1607-9. PubMed ID: 11959614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nitric oxide concentrations and cerebrospinal fluid parameters in an experimental animal model of Streptococcus pneumoniae meningitis.
    Destache CJ; Pakiz CB; Dash AK; Larsen C
    Pharmacotherapy; 1998; 18(3):612-9. PubMed ID: 9620112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cefepime is efficacious against penicillin- and quinolone-resistant pneumococci in experimental meningitis.
    Cottagnoud P; Acosta F; Cottagnoud M; Täuber MG
    J Antimicrob Chemother; 2002 Feb; 49(2):327-30. PubMed ID: 11815575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of meningitis and probenecid on the penetration of vancomycin into cerebrospinal fluid in rabbits.
    Krontz DP; Strausbaugh LJ
    Antimicrob Agents Chemother; 1980 Dec; 18(6):882-6. PubMed ID: 7235677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quinupristin/dalfopristin attenuates the inflammatory response and reduces the concentration of neuron-specific enolase in the cerebrospinal fluid of rabbits with experimental Streptococcus pneumoniae meningitis.
    Trostdorf F; Reinert RR; Schmidt H; Nichterlein T; Stuertz K; Schmitz-Salue M; Sadowski I; Brück W; Nau R
    J Antimicrob Chemother; 1999 Jan; 43(1):87-94. PubMed ID: 10381105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracellular activity of the peptide antibiotic NZ2114: studies with Staphylococcus aureus and human THP-1 monocytes, and comparison with daptomycin and vancomycin.
    Brinch KS; Tulkens PM; Van Bambeke F; Frimodt-Møller N; Høiby N; Kristensen HH
    J Antimicrob Chemother; 2010 Aug; 65(8):1720-4. PubMed ID: 20534628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of dexamethasone on therapy of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.
    París MM; Hickey SM; Uscher MI; Shelton S; Olsen KD; McCracken GH
    Antimicrob Agents Chemother; 1994 Jun; 38(6):1320-4. PubMed ID: 8092832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activity of quinupristin/dalfopristin against Streptococcus pneumoniae in vitro and in vivo in the rabbit model of experimental meningitis.
    Tarasi A; Dever LL; Tomasz A
    J Antimicrob Chemother; 1997 May; 39 Suppl A():121-7. PubMed ID: 9511076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gentamicin increases the efficacy of vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model.
    Cottagnoud P; Gerber CM; Cottagnoud M; Täuber MG
    Antimicrob Agents Chemother; 2002 Jan; 46(1):188-90. PubMed ID: 11751132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of combined ceftriaxone and dexamethasone therapy in experimental cephalosporin-resistant pneumococcal meningitis.
    Cabellos C; Martínez-Lacasa J; Tubau F; Fernández A; Viladrich PF; Liñares J; Gudiol F
    J Antimicrob Chemother; 2000 Mar; 45(3):315-20. PubMed ID: 10702550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clindamycin therapy of experimental meningitis caused by penicillin- and cephalosporin-resistant Streptococcus pneumoniae.
    París MM; Shelton S; Trujillo M; Hickey SM; McCracken GH
    Antimicrob Agents Chemother; 1996 Jan; 40(1):122-6. PubMed ID: 8787892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of fosfomycin alone and in combination with ceftriaxone or vancomycin in an experimental model of meningitis caused by two strains of cephalosporin-resistant Streptococcus pneumoniae.
    Ribes S; Taberner F; Domenech A; Cabellos C; Tubau F; Liñares J; Viladrich PF; Gudiol F
    J Antimicrob Chemother; 2006 May; 57(5):931-6. PubMed ID: 16507562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of brain injury by the nonbacteriolytic antibiotic daptomycin in experimental pneumococcal meningitis.
    Grandgirard D; Schürch C; Cottagnoud P; Leib SL
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2173-8. PubMed ID: 17371820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of CP-99,219, a new fluoroquinolone, for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.
    París MM; Hickey SM; Trujillo M; Shelton S; McCracken GH
    Antimicrob Agents Chemother; 1995 Jun; 39(6):1243-6. PubMed ID: 7574509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trovafloxacin in treatment of rabbits with experimental meningitis caused by high-level penicillin-resistant Streptococcus pneumoniae.
    Kim YS; Liu Q; Chow LL; Täuber MG
    Antimicrob Agents Chemother; 1997 May; 41(5):1186-9. PubMed ID: 9145898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of cefepime alone and in combination with vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model and in vitro.
    Gerber CM; Cottagnoud M; Neftel K; Täuber MG; Cottagnoud P
    J Antimicrob Chemother; 2000 Jan; 45(1):63-8. PubMed ID: 10629014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.